Biotechstockmarket.be offers you an overview of all Belgian biotech companies listed on the stock market. This website is a FlandersBio initiative in collaboration with KBC Securities and Euronext. FlandersBio is the umbrella organisation for the life sciences and biotech sector in Flanders.
The combined market cap of Belgian SME biotech companies gained top position in the European ranking. The fact that the number of qualifying companies is 2 to 3 times smaller than in other European countries confirms the intrinsic quality of the Belgian public biotech sector.
End April 2012, we can conclude that US biotech indices continue their rally (nasdaq biotech: +16% year-to-date), but so did the European biotechnology indices (+11%).
The ease at which ThromboGenics recently raised € 78m has put Belgian biotech at the European top at the start of 2012
Jan De Kerpel,
analyst biotech/pharma at KBC Securities
